2-Butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one BMS-186295 SR-47436 Aprovel Avapro 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2?-(1H-tetrazol-5-yl)[1,1?-biphenyl]-4-yl]methyl]- 2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one (USP) irbesartan 138402-11-6 Karvea Irbesartan BMS SR 47436 Irbesartan Zentiva Sarbevel Irbesartan teva Irbesartan Krka Irbesartan Winthrop DTXSID0023169 NSC-758696 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one J0E2756Z7N 2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one CHEBI:5959 DTXCID903169 1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- COAPROVEL COMPONENT IRBESARTAN 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one IFIRMACOMBI COMPONENT IRBESARTAN IBERSARTAN/HYDROCHLOROTHIAZIDE COMPONENT IBERSARTAN ifirmasta IBERSARTAN/HYDROCHLOROTHIAZIDE TEVA COMPONENT IBERSARTAN Sabervel IBERSARTAN/HYDROCHLOROTHIAZIDE ZENTIVA COMPONENT IBERSARTAN irbesartanum 2-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4.4)non-1-en-4-one 2-butyl-3-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)-1,3-diazaspiro(4.4)non-1-en-4-one 2-butyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)-1,3-diazaspiro(4.4)non-1-en-4-one 2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one SR47436 RefChem:57688 C09CA04 604-078-2 BMS 186295 MFCD00864464 C25H28N6O 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- CHEMBL1513 2-BUTYL-3-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1,3-DIAZASPIRO[4.4]NON-1-EN-4-ONE NCGC00095122-01 Irbetan 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one 2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one [3H]irbesartan 3-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one SMR000466306 Irbesartan free base Avapro (TN) CAS-138402-11-6 1242281-36-2 UNII-J0E2756Z7N Irbesartan? Aprovel; Irbesartan CRS Avapro; HSDB 8215 Irbesartan [USAN:USP:INN:BAN] Irbesartan; 2-Butyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 138402-11-6 (free base) Irbesartan (Avapro) 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one 2-(~2~H_9_)Butyl-3-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one Irbesartan (Standard) Spectrum_001751 IRBESARTAN [MI] IRBESARTAN [INN] IRBESARTAN [JAN] Spectrum2_001675 Spectrum3_000994 Spectrum4_001122 Spectrum5_001288 IRBESARTAN [USAN] IRBESARTAN [VANDF] IRBESARTAN [MART.] SCHEMBL4246 IRBESARTAN [USP-RS] IRBESARTAN [WHO-DD] BSPBio_002687 GTPL589 KBioGR_001603 KBioSS_002231 3-BUTYL-2-[[4-[2-(2H-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]-2,4-DIAZASPIRO[4.4]NON-3-EN-1-ONE MLS000759408 MLS001424099 BIDD:GT0347 IRBESARTAN [EMA EPAR] SCHEMBL285754 SPECTRUM1504259 SPBio_001889 GTPL6908 Irbesartan (JP18/USP/INN) Irbesartan - Bio-X trade mark orb1308006 orb3141261 IRBESARTAN [EP IMPURITY] IRBESARTAN [ORANGE BOOK] HY-B0202R KBio2_002231 KBio2_004799 KBio2_007367 KBio3_001907 IRBESARTAN [EP MONOGRAPH] IRBESARTAN [USP IMPURITY] GLXC-04552 HMS1922J05 HMS2051L08 HMS2093E16 HMS2232F23 HMS3370B06 HMS3393L08 HMS3715L04 HMS5087C17 IRBESARTAN [USP MONOGRAPH] Pharmakon1600-01504259 AVALIDE COMPONENT IRBESARTAN HY-B0202 MSK10063 Tox21_111433 AC-537 BDBM50042235 CCG-39091 NSC758696 STK645362 AKOS005576396 AKOS015895353 Irbesartan, >=98% (HPLC), powder Tox21_111433_1 AB07472 CCG-101012 DB01029 EBC-145051 FI24648 KS-1151 NC00262 NSC 758696 NCGC00095122-02 NCGC00095122-03 NCGC00095122-04 NCGC00095122-05 NCGC00095122-14 2-butyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one BI164582 SY051244 SBI-0206769.P001 I0859 NS00000387 S1507 SR-47436;BMS-186295 C07469 D00523 AB00639954-06 AB00639954_07 AB00639954_08 EN300-37158602 F036499 F861801 L000319 Q947266 SR-05000001997 SR-05000001997-1 BRD-K60038276-001-02-5 BRD-K60038276-001-03-3 BRD-K60038276-001-08-2 BRD-K60038276-001-09-0 Irbesartan, European Pharmacopoeia (EP) Reference Standard Irbesartan, United States Pharmacopeia (USP) Reference Standard Irbesartan, Pharmaceutical Secondary Standard; Certified Reference Material 2-(n-butyl)-3-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 2-Butyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one 2-butyl-3-{[2''-(1H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one 2-butyl-3-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one 2-butyl-3-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 3-((2`-(1H-Tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 3-[[2 inverted exclamation mark -(1H-Tetrazol-5-yl)-[1,1 inverted exclamation mark -biphenyl]-4-yl]methyl]-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
Mostrar todos os 186 sinônimos 
